AAAAAA
Results:
1-11
|
Results: 11
Authors:
von Eckardstein, S
Syska, A
Gromoll, J
Kamischke, A
Simoni, M
Nieschlag, E
Citation: S. Von Eckardstein et al., Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men, J CLIN END, 86(6), 2001, pp. 2585-2590
Authors:
Zitzmann, M
Brune, M
Kornmann, B
Gromoll, J
von Eckardstein, S
von Eckardstein, A
Nieschlag, E
Citation: M. Zitzmann et al., The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity, J CLIN END, 86(10), 2001, pp. 4867-4873
Authors:
Kamischke, A
Venherm, S
Ploger, D
von Eckardstein, S
Nieschlag, E
Citation: A. Kamischke et al., Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception, J CLIN END, 86(1), 2001, pp. 303-309
Authors:
Kamischke, A
Ploger, D
Venherm, S
von Eckardstein, S
von Eckardstein, A
Nieschlag, E
Citation: A. Kamischke et al., Intramuscular testosterone indecanoate with or without oral levonorgestrel: a randomized placebo feasability study for male contraception (vol 53, pg43, 2000), CLIN ENDOCR, 53(5), 2000, pp. 661-661
Authors:
Kamischke, A
Ploger, D
Venherm, S
von Eckardstein, S
von Eckardstein, A
Nieschlag, E
Citation: A. Kamischke et al., Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasability study for male contraception, CLIN ENDOCR, 53(1), 2000, pp. 43-52
Authors:
von Eckardstein, S
Cooper, TG
Rutsch, K
Meschede, D
Horst, J
Nieschlag, E
Citation: S. Von Eckardstein et al., Seminal plasma characteristics as indicators of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in men with obstructive azoospermia, FERT STERIL, 73(6), 2000, pp. 1226-1231
Authors:
Nieschlag, E
Buchter, D
von Eckardstein, S
Abshagen, K
Simoni, M
Behre, HM
Citation: E. Nieschlag et al., Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men, CLIN ENDOCR, 51(6), 1999, pp. 757-763
Authors:
Behre, HM
von Eckardstein, S
Kliesch, S
Nieschlag, E
Citation: Hm. Behre et al., Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years, CLIN ENDOCR, 50(5), 1999, pp. 629-635
Authors:
von Eckardstein, S
Gromoll, J
Terwort, N
Schmidt, A
Nieschlag, E
Citation: S. Von Eckardstein et al., Deception by chimerism, HUM REPR, 14(2), 1999, pp. 572-572
Authors:
von Eckardstein, S
Simoni, M
Bergmann, M
Weinbauer, GF
Gassner, P
Schepers, AG
Nieschlag, E
Citation: S. Von Eckardstein et al., Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples, J CLIN END, 84(7), 1999, pp. 2496-2501
Authors:
Buchter, D
von Eckardstein, S
von Eckardstein, A
Kamischke, A
Simoni, M
Behre, HM
Nieschlag, E
Citation: D. Buchter et al., Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception, J CLIN END, 84(4), 1999, pp. 1244-1249
Risultati:
1-11
|